Filing Details

Accession Number:
0001104659-19-037468
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-25 19:03:23
Reporting Period:
2019-06-21
Accepted Time:
2019-06-25 19:03:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219014 M Scott Rocklage 501 2Nd Street, Suite 350
San Francisco, CA 94107
No No No Yes
1240357 D John Diekman 501 2Nd Street, Suite 350
San Francisco, CA 94107
No No No Yes
1589314 5Am Partners Iv, Llc 501 2Nd Street, Suite 350
San Francisco, CA 94107
No No No Yes
1589315 5Am Ventures Iv, L.p. 501 2Nd Street, Suite 350
San Francisco, CA 94107
No No No Yes
1593361 5Am Co-Investors Iv, L.p. 501 2Nd Street, Suite 350
San Francisco, CA 94107
No No No Yes
1598549 J. Andrew Schwab 501 2Nd Street, Suite 350
San Francisco, CA 94107
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-06-21 240,000 $22.20 2,267,797 No 4 S Indirect See footote
Common Stock Disposition 2019-06-21 10,000 $22.20 94,489 No 4 S Indirect See footote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footote
No 4 S Indirect See footote
Footnotes
  1. These securities are held by by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
  2. These securities are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Co-Investors IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.